CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $58,826
- in 14 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$58,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 64 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-13 | Equels Thomas K. Exec. Vice Chairman/CEO/Pres. | Grant or award · Options to buy Common Stock | +371,622 | 371,622 | ||
| 2017-08-31 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +24,463 | $0.26 | $6K | 24,463 |
| 2017-08-15 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +21,336 | $0.29 | $6K | 21,336 |
| 2017-07-31 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +20,786 | $0.30 | $6K | 20,786 |
| 2017-07-15 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +18,124 | $0.34 | $6K | 18,124 |
| 2017-06-30 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +14,214 | $0.44 | $6K | 14,214 |
| 2017-06-15 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +14,212 | $0.44 | $6K | 14,212 |
| 2017-06-15 | Equels Thomas K. CEO / President | Grant or award · Options to buy Common Stock | +14,293 | $0.44 | $6K | 14,293 |
| 2017-06-08 | Equels Thomas K. CEO / President | Other acquisition · Options to buy Common Stock | +300,000 | 495,833 | ||
| 2017-04-27 | Equels Thomas K. CEO, President | Purchase | +72,464 | $0.69 | $50K | 492,919 |
| 2017-04-11 | Equels Thomas K. CEO, President | Purchase | +200,000 | $0.50 | $100K | 420,455 |
| 2016-12-22 | Equels Thomas K. CEO, President | Purchase | +68,493 | $0.73 | $50K | 220,455 |
| 2016-11-01 | Equels Thomas K. CEO,President | Purchase | +10,000 | $1.00 | $10K | 151,962 |
| 2016-07-08 | Equels Thomas K. CEO, President | Purchase | +48,000 | $0.12 | $6K | 1,703,548 |
| 2016-07-01 | Equels Thomas K. CEO,President | Purchase | +28,000 | $0.12 | $3K | 1,627,548 |
| 2016-07-01 | Equels Thomas K. CEO,President | Purchase | +28,000 | $0.12 | $3K | 1,655,548 |
| 2016-06-30 | Equels Thomas K. CEO,President | Purchase | +28,000 | $0.12 | $3K | 1,571,548 |
| 2016-06-30 | Equels Thomas K. CEO,President | Purchase | +28,000 | $0.12 | $3K | 1,599,548 |
| 2016-06-29 | Equels Thomas K. CEO,President | Purchase | +30,000 | $0.12 | $4K | 1,514,548 |
| 2016-06-29 | Equels Thomas K. CEO,President | Purchase | +29,000 | $0.12 | $3K | 1,543,548 |
Page 1 of 3 · 50 trades